Atara Biotherapeutics Inc (ATRA)

Dec 11, 2025

Is Atara's Tab-Cel The Missing Piece In A Difficult-To-Treat Cancer? - RTTNews

Dec 11, 2025

Dec 10, 2025

Panic Selling: Why Atara Biotherapeutics Inc stock could be next big winner2025 Buyback Activity & Fast Momentum Stock Entry Tips - moha.gov.vn

Dec 10, 2025

Dec 06, 2025

Atara Biotherapeutics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis

Dec 06, 2025

Dec 05, 2025

Would You Still Hold Atara Biotherapeutics Stock If It Fell Another 30%? - Trefis

Dec 05, 2025

Dec 05, 2025

Can Atara Biotherapeutics Stock Recover If Markets Fall? - Trefis

Dec 05, 2025

Dec 05, 2025

How Atara Biotherapeutics Inc. stock performs during Fed tightening cyclesWeekly Investment Report & Weekly Watchlist of Top Performers - Newser

Dec 05, 2025

Dec 05, 2025

Can Atara Biotherapeutics Inc. (AT20) stock hit consensus price targetsJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - Newser

Dec 05, 2025

Dec 05, 2025

Is Atara Biotherapeutics Inc. (AT20) stock trading at attractive multiplesJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - Newser

Dec 05, 2025

Dec 05, 2025

Why Atara Biotherapeutics Inc. (AT20) stock gets analyst attentionPortfolio Gains Summary & Daily Growth Stock Investment Tips - Newser

Dec 05, 2025

Dec 04, 2025

Is Confidence Futuristic Energetech Limited a Top Alpha Generator for Growth PortfoliosMarket Correction Analysis & Free Real-Time Trading Signals - earlytimes.in

Dec 04, 2025

Dec 04, 2025

Can Atara Biotherapeutics Inc. stock maintain operating margins2025 Key Lessons & Reliable Breakout Forecasts - Newser

Dec 04, 2025

Dec 04, 2025

Atara Biotherapeutics (ATRA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 04, 2025

Dec 04, 2025

Atara Biotherapeutics (NASDAQ:ATRA) Stock Price Passes Below 50 Day Moving AverageHere's Why - MarketBeat

Dec 04, 2025

Dec 04, 2025

Why Atara Biotherapeutics Inc. (AT20) stock could rally strongly2025 Major Catalysts & Breakout Confirmation Trade Signals - Newser

Dec 04, 2025

Dec 04, 2025

How robust is Atara Biotherapeutics Inc. (AT20) stock financial positionPortfolio Growth Summary & Accurate Entry and Exit Point Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Why analysts remain bullish on Atara Biotherapeutics Inc. stockTrade Analysis Report & Expert Curated Trade Setup Alerts - Newser

Dec 03, 2025

Dec 03, 2025

Can Atara Biotherapeutics Inc. (AT20) stock sustain revenue momentum2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser

Dec 03, 2025

Dec 02, 2025

Is Atara Biotherapeutics Inc. stock attractive for long term wealth buildingQuarterly Risk Review & Expert Verified Movement Alerts - Newser

Dec 02, 2025

Dec 02, 2025

Will Atara Biotherapeutics Inc. (AT20) stock benefit from infrastructure billJuly 2025 PostEarnings & Verified Short-Term Plans - Newser

Dec 02, 2025

Nov 30, 2025

Atara Biotherapeutics: An Empty Pipeline With Little Gas (NASDAQ:ATRA) - Seeking Alpha

Nov 30, 2025

Nov 27, 2025

Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) (PR Newswire) - Aktiellt

Nov 27, 2025

Nov 25, 2025

Perre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc. (PR Newswire) - Aktiellt

Nov 25, 2025

Nov 25, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives $21.00 Consensus Target Price from Analysts - Defense World

Nov 25, 2025

Nov 23, 2025

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 23, 2025

Nov 22, 2025

Understanding the Setup: (ATRA) and Scalable Risk - news.stocktradersdaily.com

Nov 22, 2025

Nov 21, 2025

Mizuho raises Atara Biotherapeutics stock price target on reduced expenses By Investing.com - Investing.com Canada

Nov 21, 2025

Nov 21, 2025

Atara Biotherapeutics Inc Stock Analysis and ForecastEconomic Indicators Overview & Chat With Other Investors on Daily Signals - earlytimes.in

Nov 21, 2025

Nov 21, 2025

Is Atara Biotherapeutics Inc a good long term investmentCup and Handle Formations & Budget Friendly Portfolio Growth - earlytimes.in

Nov 21, 2025

Nov 21, 2025

Mizuho Raises Price Target on Atara Biotherapeutics to $18 From $16, Keeps Outperform Rating - MarketScreener

Nov 21, 2025

Nov 20, 2025

Will Atara Biotherapeutics Inc. (AT20) stock keep high P E multiplesTrade Risk Assessment & Verified Swing Trading Watchlists - newser.com

Nov 20, 2025

Nov 20, 2025

Will Atara Biotherapeutics Inc. (AT20) stock sustain uptrend momentumJuly 2025 Opening Moves & Daily Momentum Trading Reports - newser.com

Nov 20, 2025

Nov 20, 2025

Why Atara Biotherapeutics Inc. stock could see breakout soon2025 Year in Review & Expert Verified Movement Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

Atara biotherapeutics CEO Nguyen sells $38437 in stock By Investing.com - Investing.com Canada

Nov 19, 2025

Nov 19, 2025

Can machine learning forecast Atara Biotherapeutics Inc. recoveryMarket Movement Recap & Low Risk Investment Opportunities - newser.com

Nov 19, 2025

Nov 19, 2025

Is Atara Biotherapeutics Inc. (AT20) stock attractive post correctionMarket Growth Review & Weekly Market Pulse Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How Atara Biotherapeutics Inc. (AT20) stock benefits from digital adoptionJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com

Nov 19, 2025

Nov 19, 2025

Can Atara Biotherapeutics Inc. stock resist market sell offsTrade Volume Report & Risk Controlled Stock Pick Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Atara Biotherapeutics Executives Sell Shares for Tax Obligations - TradingView

Nov 19, 2025

Nov 18, 2025

Is Atara Biotherapeutics Inc. (AT20) stock nearing a technical breakout2025 Pullback Review & Long Hold Capital Preservation Tips - newser.com

Nov 18, 2025